Citations (5)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Marie Kostine, Inge H. Briaire-de Bruijn, Arjen H. G. Cleven, Carly Vervat, Willem E. Corver, Marco W. Schilham, Els Van Beelen, Hester van Boven, Rick L. Haas, Antoine Italiano, Anne-Marie Cleton-Jansen & Judith V. M. G. Bovée. (2018) Increased infiltration of M2-macrophages, T-cells and PD-L1 expression in high grade leiomyosarcomas supports immunotherapeutic strategies. OncoImmunology 7:2.
Read now
Read now
Articles from other publishers (4)
Rincy Jimmy, Cindy Stern, Karolina Lisy & Sarahlouise White. (2017) Effectiveness of mifamurtide in addition to standard chemotherapy for high-grade osteosarcoma: a systematic review. JBI Database of Systematic Reviews and Implementation Reports 15:8, pages 2113-2152.
Crossref
Crossref
Yayan T. Sundara, Marie Kostine, Arjen H. G. Cleven, Judith V. M. G. Bovée, Marco W. Schilham & Anne-Marie Cleton-Jansen. (2016) Increased PD-L1 and T-cell infiltration in the presence of HLA class I expression in metastatic high-grade osteosarcoma: a rationale for T-cell-based immunotherapy. Cancer Immunology, Immunotherapy 66:1, pages 119-128.
Crossref
Crossref
Jolieke G. van Oosterwijk, Jakob K. Anninga, Hans Gelderblom, Anne-Marie Cleton-Jansen & Judith V.M.G. Bovée. (2013) Update on Targets and Novel Treatment Options for High-Grade Osteosarcoma and Chondrosarcoma. Hematology/Oncology Clinics of North America 27:5, pages 1021-1048.
Crossref
Crossref
Marieke L. Kuijjer, Pancras C.W. Hogendoorn & Anne-Marie Cleton-Jansen. (2013) Genome-wide analyses on high-grade osteosarcoma: Making sense of a genomically most unstable tumor. International Journal of Cancer, pages n/a-n/a.
Crossref
Crossref